Interplay between p53 and VEGF: How to prevent the guardian from becoming a villain

Cell Death and Differentiation

Volumn 20, Issue 7, 2013, Pages 852-854

  Haupt, S ^a,b   Gamell, C ^a   Wolyniec, K ^a   Haupt, Y ^a,b,c  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

4 IODO 2,5 DIMETHOXYAMPHETAMINE; PROTEIN P53; TUMOR SUPPRESSOR PROTEIN; VASCULOTROPIN; VASCULOTROPIN INHIBITOR;

CANCER THERAPY; CARCINOGENESIS; CELL PROLIFERATION; HUMAN; HYPOXIA; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; RETINOBLASTOMA; REVIEW; TUMOR CELL; TUMOR MICROENVIRONMENT;

ANIMALS; ANOXIA; CYCLIN-DEPENDENT KINASE INHIBITOR P21; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; RETINOBLASTOMA PROTEIN; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84880269353     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2013.51     Document Type: Review

References (21)

1. Pietras K, Ostman A. Exp Cell Res 2010; 316: 1324-1331.
2. Bergers G, Benjamin LE. Nat Rev Cancer 2003; 3: 401-410.
3. Farhang Ghahremani et al. Cell Death Differ 2013; 20: 888-897.
4. Schugart RC, Friedman A, Zhao R et al. Proc Natl Acad Sc USA 2008; 105: 2628-2633.
5. Goda N et al. Mol Cell Biol 2003; 23: 359-369.
6. Sermeus A, Michiels C. Cell Death Dis 2011; 2: e164.
7. Qin G et al. Proc Natl Acad Sci USA 2006; 103: 11015-11020.
8. Pillai S, Kovacs M, Chellappan S. Cancer Res 2010; 70: 4931-4940.
9. Polager S, Ginsberg D. Nat Rev Cancer 2009; 9: 738-748.
10. Ogawa M et al. Br J Cancer 1997; 75: 1617-1620.
11. Ogino S et al. Cancer Epidemiol Biomarkers Prev 2009; 18: 2513-2521.
12. Shimoda M, Mellody KT, Orimo A. Semin Cell Dev Biol 2010; 21: 19-25.
13. Lane DP, Cheok CF, Lain S. Cold Spring Harbor Perspect Biol 2010; 2: a001222.
14. Weisz L et al. Cancer Res 2004; 64: 8318-8327.
15. Addadi Y et al. Cancer Res 2010; 70: 9650-9658.
16. Jackson JG, Lozano G. Oncogene 2013; e-pub ahead of print 14 January 2013; doi: 10.1038/onc.2012.610.
17. Folkman J. N Engl J Med 1971; 285: 1182-1186.
18. Coleman ML, Ratcliffe PJ. Nat Med 2009; 15: 491-493.
19. Laurie NA et al. Nature 2006; 444: 61-66.
20. Chen Z et al. Nature 2012; 483: 613-617.
21. Pires IM et al. Cancer Res 2010; 70: 925-935.